Theraclion Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 34

Employees

  • Stock Symbol
  • ALTHE

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.66
  • (As of Friday Closing)

Theraclion General Information

Description

Theraclion specializes in developing, manufacturing, and marketing echotherapy equipment, associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules. Its products include Sonovein, Echopulse, and Epack.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 244, avenue Pierre Brossolette
  • 92240 Malakoff
  • France
+33 01
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Stock Exchange
PAR
Vertical(s)
Corporate Office
  • 244, avenue Pierre Brossolette
  • 92240 Malakoff
  • France
+33 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theraclion Stock Performance

As of 13-Nov-2026, Theraclion’s stock price is $0.66. Its current market cap is $48.4M with 73.8M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.66 $0.70 $0.46 - $1.08 $48.4M 73.8M 106K -$0.11

Theraclion Financials Summary

As of 30-Jun-2026, Theraclion has a trailing 12-month revenue of $1.18M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 54,201 41,727 11,284 11,382
Revenue 1,183 1,338 898 1,972
EBITDA (6,999) (6,761) (7,021) (4,889)
Net Income (7,883) (6,418) (6,230) (3,977)
Total Assets 16,900 17,492 11,931 20,631
Total Debt 5,649 5,803 1,349 2,156
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Theraclion Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Theraclion‘s full profile, request access.

Request a free trial

Theraclion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Theraclion specializes in developing, manufacturing, and marketing echotherapy equipment, associating therapy with focus
Therapeutic Devices
Malakoff, France
34 As of 2026

Audubon, PA
 

Plymouth, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Theraclion Competitors (25)

One of Theraclion’s 25 competitors is Globus Medical, a Formerly VC-backed company based in Audubon, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Globus Medical Formerly VC-backed Audubon, PA
HistoSonics Private Equity-Backed Plymouth, MN
Boston Scientific Corporation Marlborough, MA
CooperSurgical Corporate Backed or Acquired Trumbull, CT
Ulthera Formerly VC-backed Mesa, AZ
You’re viewing 5 of 25 competitors. Get the full list »

Theraclion Patents

Theraclion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4778571-A1 A hitu device Pending 21-Jan-2025
EP-4778572-A1 A hitu device Pending 21-Jan-2025
WO-2026159062-A1 A hitu device Pending 21-Jan-2025
WO-2026159070-A1 A hitu device and associated methods Pending 21-Jan-2025
EP-4454586-A1 System for gathering treatment data and/or generating a treatment plan for treating a patient with hitu and method for defining treatment parameters Inactive 26-Apr-2023 A61B90/37
To view Theraclion’s complete patent history, request access »

Theraclion Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Theraclion Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Theraclion‘s full profile, request access.

Request a free trial

Theraclion Investments (1)

Theraclion’s most recent deal was a Joint Venture with Theraclion China. The deal was made on 24-Apr-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Theraclion China 24-Apr-2017 Joint Venture Surgical Devices
To view Theraclion’s complete investments history, request access »

Theraclion ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Theraclion’s complete esg history, request access »

Theraclion FAQs

  • When was Theraclion founded?

    Theraclion was founded in 2004.

  • Where is Theraclion headquartered?

    Theraclion is headquartered in Malakoff, France.

  • What is the size of Theraclion?

    Theraclion has 34 total employees.

  • What industry is Theraclion in?

    Theraclion’s primary industry is Therapeutic Devices.

  • Is Theraclion a private or public company?

    Theraclion is a Public company.

  • What is Theraclion’s stock symbol?

    The ticker symbol for Theraclion is ALTHE.

  • What is the current stock price of Theraclion?

    As of 13-Nov-2026 the stock price of Theraclion is $0.66.

  • What is the current market cap of Theraclion?

    The current market capitalization of Theraclion is $48.4M.

  • What is Theraclion’s current revenue?

    The trailing twelve month revenue for Theraclion is $1.18M.

  • Who are Theraclion’s competitors?

    Globus Medical, HistoSonics, Boston Scientific, CooperSurgical, and Ulthera are some of the 25 competitors of Theraclion.

  • What is Theraclion’s annual earnings per share (EPS)?

    Theraclion’s EPS for 12 months was -$0.11.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process